SCHEMBL6001100

SCHEMBL6001100

O=C(O)c1ccc(CNCc2nc(-c3ccc(NCCc4ccc(C5CCCCC5)cc4)cc3)cs2)o1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
MRE11 P49959 1/20 0.38
TRPA1 O75762 1/20 0.36
HRH3 Q9Y5N1 1/20 0.35
NAMPT P43490 1/20 0.35
DGAT1 O75907 2/20 0.34
ADRB3 P13945 4/20 0.34
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
DHODH Q02127 1/20 0.34
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001095 0.83 MRE11 (0.37) MRE11TRPA1DHODHSTAT3
SCHEMBL6000064 0.83 NPC1 (0.41) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL6001067 0.83 RAB9A (0.42) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL5999739 0.82 MRE11 (0.40) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL5999229 0.81 NPC1 (0.41) LMNANPC1RAB9AMEN1KMT2A
SCHEMBL6001034 0.81 RAB9A (0.41) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL6000151 0.81 GCGR (0.41) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6000108 0.81 MRE11 (0.41) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL5999747 0.79 OPRM1 (0.41) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL5999851 0.79 MEN1 (0.41) NPC1RAB9AMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 ALDH1A1 1733/4885LMNA 4522/4885NPC1 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.